Navigation Links
CSL Behring Announces FDA Approval of Berinert(R), First and Only Therapy Approved for the Treatment of Acute Abdominal and Facial Attacks of Hereditary Angioedema in U.S.
Date:10/12/2009

e headache, abdominal pain, nausea, muscle spasms, pain, diarrhea, and vomiting.

Berinert has not been evaluated in pregnant women or nursing mothers; benefits of treatment should be weighed against potential risks in pregnant women, and Berinert should be given to nursing mothers only if clearly needed. Safety and efficacy of Berinert have not been established in children (ages 0 through 12) or in the geriatric population. For more information, including full prescribing information, visit www.berinert.com.

About CSL Behring

CSL Behring is a global leader in the plasma protein biotherapeutics industry. Passionate about improving the quality of patients' lives, CSL Behring manufactures and markets a range of safe and effective plasma-derived and recombinant products and related services. The company's therapies are used in the treatment of immune deficiency disorders, hemophilia, von Willebrand disease, other bleeding disorders and inherited emphysema. Other products are used for the prevention of hemolytic diseases in the newborn, in cardiac surgery, organ transplantation and in the treatment of burns. The company also operates one of the world's largest plasma collection networks, CSL Plasma. CSL Behring is a subsidiary of CSL Limited, a biopharmaceutical company with headquarters in Melbourne, Australia. For more information, visit www.cslbehring.com.

    Contacts:

    Sheila A. Burke, Director
    Communications & Public Relations
    CSL Behring
    +1-610-878-4209 (o)
    +1-484-919-2618 (m)
    Sheila.Burke@cslbehring.com

    Jeff Hoyak
    MCS
    +1-908-234-9900, ext. 312
    '/>"/>
SOURCE CSL Behring
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. CSL Behring Receives Orphan-Drug Exclusivity for RiaSTAP(TM), First and Only Approved Treatment of Acute Bleeding Episodes in Patients with Congenital Fibrinogen Deficiency
2. Over $10 Million of CSL Behrings Privigen Was Sold in the U.S. During the Third Quarter of 2008
3. CSL Behring Submits BLA Requesting Approval of C1-Esterase Inhibitor for the Treatment of Hereditary Angioedema
4. CSL Behring Study in Animal Models Shows Feasibility of Developing a Half-Life Extended Recombinant FVIIa that Retains Biologic Activity
5. CSL Behring Reaches Primary Endpoint in Clinical Study of C1-INH for Treatment of Hereditary Angioedema
6. Child Neurology Foundation Announces the Launch of Infantilespasmsinfo.org
7. Elbit Imaging Ltd. Announces Sale of Plaza Centers Shares
8. Onyx Pharmaceuticals Announces Investor Teleconference and Webcast
9. Kensey Nash Corporation Announces Its First Quarter Fiscal Year 2010 Earnings Release Date and Teleconference
10. ADVENTRX Pharmaceuticals Announces Closing of Financing
11. Stereotaxis Announces Pricing of $26 Million Common Stock Offering
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... 2015 Dynatronics Corporation (NASDAQ: DYNT ) today ... to the Company,s Board of Directors effective March 23, 2015, ... 2014 of board member Joseph Barton .  ... Board of Directors represents an important step forward for the ... of Dynatronics.  "Rich is a proven leader and is well-known ...
(Date:3/27/2015)... 27, 2015 The Temple Health & Bioscience District ... 5,000-square-foot building at 1802 South First St. in the Temple ... the City of Temple to receive ... the Central Texas Veterans Health Care System, the new facility ... early stage biotechnology and life science companies. ...
(Date:3/27/2015)... 2015 XRpro Sciences, Inc., a provider ... development services which features high throughput transporter and ... financial results for the year ended December 31, ... of XRpro Sciences commented, "We have completed a ... stage to commercial stage in large part by ...
Breaking Medicine Technology:Dynatronics Announces Appointment of Richard J. Linder to Board of Directors 2Temple Health & Bioscience District Relocates, Offers Office And Lab Space To Biotech Companies 2XRpro Sciences Announces Fiscal 2014 Financial Results 2XRpro Sciences Announces Fiscal 2014 Financial Results 3XRpro Sciences Announces Fiscal 2014 Financial Results 4
... 21, 2011 VIVUS, Inc. (Nasdaq: VVUS ) ... Food and Drug Administration (FDA) for the New Drug Application ... obesity.  The meeting occurred on January 19th at the FDA,s ... the FDA and VIVUS, management and consultants.  At this meeting ...
... held) today announced that they have signed a multi-year ... clear, and manufacture assays for the Abbott Molecular FDA ... terms have not been disclosed. IMDx ... evolving clinical needs. The tests are designed utilizing IMDx,s ...
Cached Medicine Technology:VIVUS Provides Regulatory Update on QNEXA NDA 2VIVUS Provides Regulatory Update on QNEXA NDA 3Intelligent Medical Devices, Inc. (IMDx) Enters into an Agreement with Abbott for the Distribution of a Broad Menu of Molecular Tests 2
(Date:3/27/2015)... (PRWEB) March 27, 2015 The ... Germany” is an essential source of information on ... landscape in Germany. Germany’s increasingly elderly population and ... its pharmaceutical market. In 2013, the elderly accounted ... increase at Compound Annual Growth Rate (CAGR) of ...
(Date:3/27/2015)... PRUSSIA, PA and LONDON, UK (PRWEB) March 27, 2015 ... President of DrugDev SiteStart Melissa (Liss) Easy was named ... , The 40 Under 40 list spotlights 40 ... for their professional accomplishments and community involvement. Winners are ... in a special supplement of the Philadelphia Business Journal. ...
(Date:3/27/2015)... 27, 2015 According to Health ... born with Neonatal Abstinence Syndrome (NAS) are causing alarm ... the painful withdrawal process for a month of their ... crying, diarrhea, and vomiting. The condition is precipitated by ... alcohol addiction treatment (and employing medically assisted drug treatment) ...
(Date:3/27/2015)... California’s ongoing worst ever drought, and the ... United States Northeast, are both manifestations of the same ... creating changes in the atmosphere’s “energy balance,” according to ... researcher, speaking on the Sharon Kleyne Hour™ Power of ... warmer and dryer global climate but also greater and ...
(Date:3/27/2015)... Atlanta, Georgia (PRWEB) March 27, 2015 To ... and shade issues, Super-Sod spent a year filming this video ... lawn needs and the shady environment it's often expected to ... shade. , All plants need light to survive. Anytime a ... essentially being put on a diet. Many homeowners try to ...
Breaking Medicine News(10 mins):Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 2Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 3Health News:Germany Healthcare, Regulatory and Reimbursement Landscape Market Research Report Available at RnRMarketResearch.com 4Health News:DrugDev Founder Melissa Easy is 2015 Philadelphia Business Journal 40 Under 40 Honoree 2Health News:In Florida Only 10% of Pregnant Mothers Are Referred to Drug Rehab Despite Testing Positive for Narcotics 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 2Health News:California Drought, Boston Blizzards Both Attributed to Global Climate Change Reports Climatologist to Fresh Water Advocate 3Health News:For Spring Turf Planting Season, Super-Sod Created a New How-To Video Entitled "Two Views on Shade and Turf" 2
... diabetic pregnancies have a greater risk of childhood obesity, ... Health shows breastfeeding can reduce this threat. Epidemiologist ... children of diabetic pregnancies and 399 of non-diabetic pregnancies ... of breastfeeding on the growth of body mass index ...
... News) -- Middle-school kids who participate in lots of sports ... research finds. Yet, students with teammates who smoke are ... is more pronounced among girls. "This result suggests that ... even though there might be a protective effect overall of ...
... FRANCISCO There is growing evidence that supports an association between ... thigh bone, typically without trauma and the use of ... incidence caused by osteoporosis. While the risk for suffering an ... just 1 in 1,000 patients after six years of ...
... 7, 2012). Researchers at Virginia Commonwealth University Medical ... Young Neurosurgical Center (Richmond, VA) and Old Dominion ... Wilms tumor 1 protein (WT1) results in downregulation ... lines and reduces the characteristic invasiveness exhibited by ...
... MONDAY, Feb. 6 (HealthDay News) -- ,When it comes ... of defense is lifestyle changes such as losing weight and ... get blood sugar levels under control, the American College of ... treatment that should be given. If metformin alone ...
... forests, fields, rivers -- and thereby on humans that breathe, ... comprehensive comparison of computer-based simulations from all over the world ... from ecosystems to agriculture to water supplies and health will ... be provided by more than two dozen research groups from ...
Cached Medicine News:Health News:Breastfeeding can reduce risk of childhood obesity 2Health News:Halting bone-building osteoporosis drug use cuts risk for additional atypical femur fracture in half 2Health News:CD97 gene expression and function correlate with WT1 protein expression and glioma invasiveness 2Health News:CD97 gene expression and function correlate with WT1 protein expression and glioma invasiveness 3Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 2Health News:Metformin Preferred Drug for Type 2 Diabetes, Experts Say 3Health News:Quantifying climate impacts: New comprehensive model comparison launched 2Health News:Quantifying climate impacts: New comprehensive model comparison launched 3
CCR Medical fiberoptic green system laryngoscope handles., ,OUTSTANDING PERFORMANCE, QUALITY, AND PRICING MAKE OUR FIBEROPTIC SELECTION MOST ECONOMICAL....
CCR Medical conventional laryngoscopes....
CCR Medical conventional laryngoscope handles....
... The Intubating LMA™ Airway. , ... or unexpected difficult airway, the LMA Fastrach™ ... without moving the head or neck. The ... attempts. , ,Selected by emergency teams ...
Medicine Products: